Heart Metabolics Overview

  • Founded
  • 2004
Founded
  • Status
  • Out of Business
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Out of Business

Heart Metabolics General Information

Description

Developer of pharmaceutical therapy designed to help in the treatment of hypertrophic cardiomyopathy (HCM). The company's therapy is used in developing perhexiline as a therapeutic for all types of treatment-related to HCM, enabling patients to get cured who are presently in search for the treatment.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 20B Beckett Way
  • Dublin 12
  • Ireland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Heart Metabolics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Nov-2017 000.00 Completed Out of Business
3. Later Stage VC 01-Jan-2015 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 17-Apr-2014 $20M $24M Completed Generating Revenue
1. Early Stage VC 04-Jan-2013 $4M $4M Completed Generating Revenue
To view Heart Metabolics’s complete valuation and funding history, request access »

Heart Metabolics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial